Related Experiment Video
Updated: Jan 18, 2026

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
Lightweight breast implants: a novel solution for breast augmentation and reconstruction mammaplasty
Jacky Govrin-Yehudain1, Haim Dvir1, Dina Preise1
1Dr Govrin-Yehudain is President, Dr Haim is Chief Technology Officer, and Mr Govreen-Segal is Chief Executive Officer, G&G Biotechnology Ltd., Haifa, Israel. Dr Govrin-Yehudain is also Founding Plastic Surgeon, Beit Harofim Medical Center, Haifa, Israel. Dr Preise is a Senior Intern in the Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, Israel. Mr Govrin-Yehudain is a Medical Student, Bar Ilan University, Ramat Gan, Israel.
Novel lightweight breast implants reduce tissue strain and deformation, improving long-term outcomes. This innovation addresses implant weight as a key factor in breast tissue compromise, enhancing patient safety and satisfaction.
Area of Science:
- Plastic Surgery
- Biomedical Engineering
- Biomaterials
Background:
- Breast augmentation and reconstruction mammaplasty are common procedures with high patient satisfaction.
- Long-term complications include breast tissue atrophy, ptosis, and inframammary fold breakdown, linked to implant-induced mechanical stress.
- Implant weight, not volume, is increasingly recognized as the primary driver of tissue deformation and compromise.
Purpose of the Study:
- To introduce a novel lightweight breast implant designed to mitigate long-term complications associated with traditional implants.
- To evaluate the potential of reduced implant weight in preserving breast tissue integrity and stability.
- To improve patient safety and satisfaction by minimizing tissue compromise and the need for reoperation.
Main Methods:
- Development of a novel lightweight breast implant (B-Lite®) with reduced weight (up to 30%) while maintaining size and form.
- Utilizing standard surgical procedures for implantation.
- Assessing the safety and efficacy of the lightweight implant through CE marking and established human use protocols.
Main Results:
- The B-Lite® implant offers a significant weight reduction compared to traditional implants.
- The device is safe for human use and can be implanted using standard procedures.
- Projected to reduce mechanical strain on breast tissues, conserving tissue stability.
Conclusions:
- Lightweight breast implants represent a significant advancement in addressing the mechanical limitations of traditional implants.
- Reduced implant weight can mitigate long-term tissue compromise, deformation, and potential reoperations.
- This innovation holds promise for enhancing patient outcomes and satisfaction in breast augmentation and reconstruction.
More Related Videos
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
13:43Intraductal Delivery and X-ray Visualization of Ethanol-Based Ablative Solution for Prevention and Local Treatment of Breast Cancer in Mouse Models
Published on: April 1, 2022